Sign In
Buy ABBV
$217.07
+1.64 (+0.761%)
At Close: Jun 03, 2026
The High Dividend Yield Bull Market: 3 Compelling 6% Yields
04:51am, Monday, 02'nd Mar 2026
High-yield stocks are outperforming, with a clear rotation from growth to value driving strong returns for dividend-focused investors. Safe, high-yielding companies are still trading at discounts. The
AbbVie Inc. $ABBV Shares Sold by 111 Capital
03:06am, Monday, 02'nd Mar 2026
111 Capital lessened its position in AbbVie Inc. (NYSE: ABBV) by 77.4% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 4,411 shares of
AbbVie Inc. $ABBV is Argent Trust Co’s 8th Largest Position
04:52am, Saturday, 28'th Feb 2026
Argent Trust Co lowered its stake in AbbVie Inc. (NYSE: ABBV) by 1.5% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 205,
Best Dividend Aristocrats For March 2026
12:21pm, Friday, 27'th Feb 2026
The ProShares S&P 500 Dividend Aristocrat ETF (NOBL) is up 9.39% YTD in 2026, decisively outperforming SPY's 1.08%. Dividend Aristocrats are regaining momentum after a weak 2025, with 55 outpacing SPY
Why AbbVie (ABBV) is a Top Value Stock for the Long-Term
10:41am, Friday, 27'th Feb 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
DNB Asset Management AS Lowers Holdings in AbbVie Inc. $ABBV
06:04am, Friday, 27'th Feb 2026
DNB Asset Management AS lowered its stake in shares of AbbVie Inc. (NYSE: ABBV) by 1.8% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 493,795 shares of the
Aster Capital Management DIFC Ltd Takes $2.06 Million Position in AbbVie Inc. $ABBV
04:36am, Friday, 27'th Feb 2026
Aster Capital Management DIFC Ltd bought a new position in shares of AbbVie Inc. (NYSE: ABBV) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commiss
Andra AP fonden Grows Stock Holdings in AbbVie Inc. $ABBV
03:14am, Friday, 27'th Feb 2026
Andra AP fonden increased its position in AbbVie Inc. (NYSE: ABBV) by 43.4% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SE
Market Today: Nvidia Beats, WBD Bidding War, Uber Air
05:35pm, Thursday, 26'th Feb 2026
Guru Stock PicksMS Global Franchise Portfolio has made the following transactions:Reduce in MSCI by 17.11%Sold out in FDSAdd in LSE: EXPN by 13.74%New position i
Where Will AbbVie Be in 5 Years?
03:15pm, Thursday, 26'th Feb 2026
The stock is performing well thanks to AbbVie's still-growing immunology franchise. The company looks able to launch new products through at least 2031.
First Look: Nvidia beats, Stellantis pivots, WBD bid war
07:39am, Thursday, 26'th Feb 2026
Stock News Nvidia posts record quarter, upbeat outlook: Nvidia (NVDA) reported Q4 revenue of $68.13B with data center sales at $62.3B (91% of total) and guided
Health Care Q4 Dividend Roundup: Merck Offers Thicker Dividend Cushion Than AbbVie
07:30am, Thursday, 26'th Feb 2026
Merck & Co. (MRK) is upgraded to buy, driven by improving dividend cushion ratio (DCR) and robust FQ4 2025 earnings recovery. MRK's dividend safety strengthens, with a projected DCR of 2.57x for 2026,
Pre-Market Stock Futures: Futures are trading higher this morning, but what a difference a day makes after a "Meltdown Monday." Stocks rallied on Tuesday, and all major indices closed higher. While no
AbbVie Inc. $ABBV Shares Bought by Empirical Asset Management LLC
05:40am, Wednesday, 25'th Feb 2026
Empirical Asset Management LLC increased its position in AbbVie Inc. (NYSE: ABBV) by 206.3% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exc
Here's Why AbbVie (ABBV) is a Strong Growth Stock
10:46am, Tuesday, 24'th Feb 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
